SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Investment Income, Interest
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Investment Income, Interest of $90 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-09-24
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. investment income, interest for the quarter ending 2026-06-30 was $90.00, a 11.11% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. investment income, interest for the quarter ending 2026-03-31 was $209.00.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. investment income, interest for the quarter ending 2025-12-31 was $523.00, a 17333.33% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. investment income, interest for the quarter ending 2025-09-30 was $486.00, a 80.74% decline year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. investment income, interest for fiscal 2025 was $1.09K, a 97.14% decline from fiscal 2024.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. investment income, interest for fiscal 2024 was $38.14K, a 51.80% decline from fiscal 2023.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. investment income, interest for fiscal 2023 was $79.12K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $90.00 10-Q · filed 2026-09-24 | $299.00 10-Q · filed 2026-09-24 | $822.00 derived: sum of 3 quarters · filed 2026-09-24 | $1.31K derived: sum of 4 quarters · filed 2026-09-24 |
| 2026-03-31 | $209.00 10-Q · filed 2026-05-15 | $732.00 derived: sum of 2 quarters · filed 2026-05-15 | $1.22K derived: sum of 3 quarters · filed 2026-05-15 | $1.30K derived: sum of 4 quarters · filed 2026-09-24 |
| 2025-12-31 | $523.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.01K derived: sum of 2 quarters · filed 2026-03-31 | $1.09K derived: sum of 3 quarters · filed 2026-09-24 | $1.09K 10-K · filed 2026-03-31 |
| 2025-09-30 | $486.00 10-Q · filed 2025-11-13 | $567.00 derived: sum of 2 quarters · filed 2026-09-24 | $567.00 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $81.00 10-Q · filed 2026-09-24 | $81.00 10-Q · filed 2026-09-24 | ||
| 2024-12-31 | $3.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.53K derived: sum of 2 quarters · filed 2026-03-31 | $16.68K derived: sum of 3 quarters · filed 2026-03-31 | $38.14K 10-K · filed 2026-03-31 |
| 2024-09-30 | $2.52K 10-Q · filed 2025-11-13 | $16.68K derived: sum of 2 quarters · filed 2025-11-13 | $38.13K 10-Q · filed 2025-11-13 | $60.53K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $14.16K 10-Q · filed 2025-08-13 | $35.61K 10-Q · filed 2025-08-13 | $58.01K derived: sum of 3 quarters · filed 2025-08-13 | $78.77K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $21.45K 10-Q · filed 2025-05-08 | $43.85K derived: sum of 2 quarters · filed 2025-05-08 | $64.61K derived: sum of 3 quarters · filed 2025-05-08 | $83.88K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $22.40K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $43.16K derived: sum of 2 quarters · filed 2025-02-26 | $62.43K derived: sum of 3 quarters · filed 2025-02-26 | $79.12K 10-K · filed 2025-02-26 |
| 2023-09-30 | $20.77K 10-Q · filed 2024-11-13 | $40.03K derived: sum of 2 quarters · filed 2024-11-13 | $56.72K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $19.27K 10-Q · filed 2024-09-04 | $35.95K 10-Q · filed 2024-09-04 | ||
| 2023-03-31 | $16.69K 10-Q/A · filed 2024-09-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |